Treatment with Ex Vivo Expanded Autologous Regulatory CD4+CD25+Foxp3+CD127low T Cells Restores the Balance of the Immune System in Patients with Remitting Multiple Sclerosis

[1]  R. Luong,et al.  CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells. , 2014, Blood.

[2]  J. Bluestone,et al.  Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity , 2013, Front. Immunol..

[3]  A. Ganser,et al.  Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity. , 2011, Experimental hematology.

[4]  Z. Amoura,et al.  Human FoxP3+ regulatory T cells in systemic autoimmune diseases. , 2011, Autoimmunity reviews.

[5]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[6]  J. Buckner.  Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases , 2010, Nature Reviews Immunology.

[7]  K. Venken,et al.  Disturbed regulatory T cell homeostasis in multiple sclerosis. , 2010, Trends in molecular medicine.

[8]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[9]  J. McCune,et al.  Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. , 2007, Journal of immunological methods.

[10]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[11]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[12]  H. Hartung,et al.  Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis - results of a retrospective multicenter observational study over five years , 2005, Multiple sclerosis.

[13]  R. Toes,et al.  Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. , 2005, Arthritis and rheumatism.

[14]  J. Bluestone,et al.  Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function , 2004 .

[15]  R. Andreesen,et al.  Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells , 2004, Cancer Cell International.

[16]  W. Kuis,et al.  CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.

[17]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[18]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[19]  D. Alarcón-Segovia,et al.  Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission , 2003, Lupus.

[20]  F. Powrie,et al.  Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.

[21]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[22]  S. Miller,et al.  EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4 , 2022 .

[23]  A. Mellor,et al.  Differential Susceptibility of Heart, Skin, and Islet Allografts to T Cell-Mediated Rejection1 , 2001, The Journal of Immunology.

[24]  R Kikinis,et al.  Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. , 2000, Archives of neurology.

[25]  김민성,et al.  원저 : 건선환자의 말초혈액 내 CD4+CD25+Foxp3+ Regulatory T 세포와 CD4+CD25.Foxp3+ T 세포 수에 관한 연구 , 2015 .

[26]  A. Torgashina,et al.  Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. , 2007, Advances in experimental medicine and biology.

[27]  Svetlana Ten,et al.  Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.